An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes

Clinical trial NCT00960076 · COMPLETED

Trial details

NCT number: NCT00960076
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2009-08-01
Primary completion: 2010-10-01
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.